References
- Vuyyuru SK, Kedia S, Sahu P, Ahuja V. Immunemediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis. JGH Open. 2022;6(2):100–11.
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79–94.
- Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. Journal of Translational Medicine. 2019;17(1):419.
- Kofla-Dlubacz A, Pytrus T, Akutko K, Sputa-Grzegrzolka P, Piotrowska A, Dziegiel P. Etiology of IBD-Is It Still a Mystery? Int J Mol Sci. 2022;23(20).
- Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis(). Dis Mon. 2019;65(12):100851.
- Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, et al. Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2022;18(1):32–43.
- Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences. 2022;23(2):786.
- Li W, Qiu X, Ma H, Geng Q. Incidence and long-term specific mortality trends of metabolic syndrome in the United States. Front Endocrinol (Lausanne). 2022;13:1029736.
- Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients. 2020;12(5).
- Jovanovic M, Simovic Markovic B, Gajovic N, Jurisevic M, Djukic A, Jovanovic I, et al. Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression. World J Gastroenterol. 2019;25(43):6465–82.
- Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2).
- Griesenauer B, Paczesny S. The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Frontiers in Immunology. 2017;8.
- Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cellular & Molecular Immunology. 2023;20(3):217–51.
- Rezaianzadeh A, Namayandeh SM, Sadr SM. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease? Int J Prev Med. 2012;3(8):552–8.
- Ikeya K, Hanai H, Sugimoto K, Osawa S, Kawasaki S, Iida T, et al. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. J Crohns Colitis. 2016;10(3):286–95.
- Pabla BS, Schwartz DA. Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterol Clin North Am. 2020;49(4):671–88.
- Jauregui-Amezaga A, Geerits A, Das Y, Lemmens B, Sagaert X, Bessissow T, et al. A Simplified Geboes Score for Ulcerative Colitis. Journal of Crohn's and Colitis. 2016;11(3):305–13.
- Jovanovic M, Gajovic N, Jurisevic M, Markovic B, Maric V, Jovanovic M, et al. Fecal sST2 correlates with disease severity of ulcerative colitis. Vojnosanitetski pregled. 2018;76:26-.
- Scoville EA, Allaman MM, Brown CT, Motley AK, Horst SN, Williams CS, et al. Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling. Metabolomics. 2018;14(1):17.
- Ding W, Zou G-L, Zhang W, Lai X-N, Chen H-W, Xiong L-X. Interleukin-33: Its Emerging Role in Allergic Diseases. Molecules. 2018;23(7):1665.
- Drake LY, Kita H. IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017;278(1):173–84.
- Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (Lond). 2011;8(1):22.
- Guo H, Bossila EA, Ma X, Zhao C, Zhao Y. Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions. Cells. 2022;11(20):3237.
- Griesenauer B, Paczesny S. The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Front Immunol. 2017;8:475.
- Lang T, Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunology & Cell Biology. 2007;85(6):425–34.
- Xiong X, Liao X, Qiu S, Xu H, Zhang S, Wang S, et al. CXCL8 in Tumor Biology and Its Implications for Clinical Translation. Front Mol Biosci. 2022;9:723846.
- Wera O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. Journal of Clinical Medicine. 2016;5(12):118.
- Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, et al. Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophages. Int Immunopharmacol. 2018;56:217–21.
- Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases. Theranostics. 2017;7(6):1543–88.
- Monserrat-Mesquida M, Quetglas-Llabres M, Capo X, Bouzas C, Mateos D, Pons A, et al. Metabolic Syndrome is Associated with Oxidative Stress and Proinflammatory State. Antioxidants (Basel). 2020;9(3).